A dangerous dilemma : management of infectious intracranial aneurysms complicating endocarditisPETERS, Philip J; HARRISON, Taylor; LENNOX, Jeffrey L et al.Lancet. Infectious diseases (print). 2006, Vol 6, Num 11, pp 742-748, issn 1473-3099, 7 p.Article

Liver Enzymes Elevation and Immune Reconstitution Among Treatment-Naïve HIV-Infected Patients Instituting Antiretroviral TherapyOFOTOKUN, Ighovwerha; SMITHSON, Sarah E; CHENGXING LU et al.The American journal of the medical sciences. 2007, Vol 334, Num 5, pp 334-341, issn 0002-9629, 8 p.Article

Pharmacokinetics of an Indinavir-Ritonavir-Fosamprenavir Regimen in Patients with Human Immunodeficiency VirusOFOTOKUN, Ighovwerha; ACOSTA, Edward P; LENNOX, Jeffrey L et al.Pharmacotherapy. 2008, Vol 28, Num 1, pp 74-81, issn 0277-0008, 8 p.Article

Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000HORSBURGH, C. Robert; GETTINGS, Jill; ALEXANDER, Lorraine N et al.Clinical infectious diseases. 2001, Vol 33, Num 11, pp 1938-1943, issn 1058-4838Article

Imported malaria at an inner-city hospital in the United StatesVICAS, Aurora E; ALBRECHT, Helmut; LENNOX, Jeffrey L et al.The American journal of the medical sciences. 2005, Vol 329, Num 1, pp 6-12, issn 0002-9629, 7 p.Article

Integrated Population Pharmacokinetic/Viral Dynamic Modelling of Lopinavir/Ritonavir in HIV-1 Treatment-Naïve PatientsKUN WANG; D'ARGENIO, David Z; ACOSTA, Edward P et al.Clinical pharmacokinetics. 2014, Vol 53, Num 4, pp 361-371, issn 0312-5963, 11 p.Article

Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women : Associations with immune statusSULLIVAN, Sharon T; MANDAVA, Usha; EVANS-STRICKFADEN, Tammy et al.Journal of virology. 2005, Vol 79, Num 15, pp 9799-9809, issn 0022-538X, 11 p.Article

A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study TeamABERG, Judith A; WILLIAMS, Paige L; TUN LIU et al.The Journal of infectious diseases. 2003, Vol 187, Num 7, pp 1046-1052, issn 0022-1899, 7 p.Article

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture methodCUMMINS, James E; VILLANUEVA, Julie M; HART, Clyde E et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 9, pp 4081-4088, issn 0095-1137, 8 p.Article

HIV in body fluids during primary HIV infection : implications for pathogenesis, treatment and public healthPILCHER, Christopher D; SHUGARS, Diane C; ERON, Joseph J et al.AIDS (London). 2001, Vol 15, Num 7, pp 837-845, issn 0269-9370Article

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsERON, Joseph J; COOPER, David A; LOUTFY, Mona R et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 587-596, issn 1473-3099, 10 p.Article

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRKROCKSTROH, Jiirgen K; LENNOX, Jeffrey L; DINUBILE, Mark J et al.Clinical infectious diseases. 2011, Vol 53, Num 8, pp 807-816, issn 1058-4838, 10 p.Article

Pandemic Influenza: Implications for Programs Controlling for HIV Infection, Tuberculosis, and Chronic Viral HepatitisHEFFELFINGER, James D; PATEL, Pragna; LENNOX, Jeffrey L et al.American journal of public health (1971). 2009, Vol 99, issn 0090-0036, S333-S339, SUP2Article

Female Genital Tract Shedding of CXCR4-Tropic HIV Type 1 Is Associated with a Majority Population of CXCR4-Tropic HIV Type 1 in Blood and Declining CD4⁺ Cell CountsHAALAND, Richard E; SULLIVAN, Sharon T; EVANS-STRICKFADEN, Tammy et al.AIDS research and human retroviruses. 2012, Vol 28, Num 11, pp 1524-1532, issn 0889-2229, 9 p.Article

Tuberculosis Biomarker and Surrogate Endpoint Research RoadmapNAHID, Payam; SAUKKONEN, Jussi; CAMPBELL, Thomas B et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 8, pp 972-979, issn 1073-449X, 8 p.Article

Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infectionFREEL, Stephanie A; FISCUS, Susan A; PILCHER, Christopher D et al.AIDS (London). 2003, Vol 17, Num 14, pp 2025-2033, issn 0269-9370, 9 p.Article

The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretionsVILLANUEVA, Julie M; ELLERBROCK, Tedd V; LENNOX, Jeffrey L et al.The Journal of infectious diseases. 2002, Vol 185, Num 2, pp 170-177, issn 0022-1899Article

Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulcerationWRIGHT, Thomas C; SUBBARAO, Shambavi; ELLERBROCK, Tedd V et al.American journal of obstetrics and gynecology. 2001, Vol 184, Num 3, pp 279-285, issn 0002-9378Article

Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell ActivationVINIKOOR, Michael J; COPE, Anna; GAY, Cynthia L et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 505-508, issn 1525-4135, 4 p.Article

Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced womenKELLEY, Colleen F; SULLIVAN, Sharon T; LENNOX, Jeffrey L et al.AIDS (London). 2010, Vol 24, Num 9, pp 1361-1366, issn 0269-9370, 6 p.Article

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment- Experienced Patients with Drug- Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III TrialsSTEIGBIGEL, Roy T; COOPER, David A; YENI, Patrick et al.Clinical infectious diseases. 2010, Vol 50, Num 4, pp 605-612, issn 1058-4838, 8 p.Article

Guidelines for the management of chronic kidney disease in HIV-infected patients : Recommendations of the HIV medicine association of the infectious diseases society of americaGUPTA, Samir K; EUSTACE, Joseph A; LENNOX, Jeffrey L et al.Clinical infectious diseases. 2005, Vol 40, Num 11, pp 1559-1585, issn 1058-4838, 27 p.Article

Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000LEONARD, Michael K; LARSEN, Nina; DRECHSLER, Henning et al.Clinical infectious diseases. 2002, Vol 34, Num 7, pp 1002-1007, issn 1058-4838Article

Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretionsELLERBROCK, Tedd V; LENNOX, Jeffrey L; PARRISH-KOHLER, Edith E et al.The Journal of infectious diseases. 2001, Vol 184, Num 1, pp 28-36, issn 0022-1899Article